Massachusetts insurers say ACA, pricey drugs to blame for financial losses

Many Massachusetts health insurers are struggling to make profits after experiencing financial challenges last year, the Boston Business Journal reports. Among the reasons insurers gave for negative operating margins were intense regulatory pressure, expensive drugs and low reimbursements from the state. "Our results are driven by several factors including the cost of complying with the [Affordable Care Act], competitive pressures on premiums, our continued investment in new technologies and services for our customers, and the rising costs of so-called specialty medications," said Allen Maltz, chief financial officer at BlueCross BlueShield of Massachusetts, which saw the highest operating loss, $51.8 million, in the second quarter of fiscal 2015. Article

Suggested Articles

An estimated 73 million Americans with commercial health insurance face limited choices, according to a new American Medical Association study.

Absent adequate reimbursement for time spent on complex patient care, specialists are finding it harder to sustain their practices.

Tennessee released its proposal to CMS to become the first state to convert federal Medicaid funding into a block grant.